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Abstract
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Introduction—Velocardiofacial syndrome (VCFS) has been identified as an important risk
factor for psychoses, with upto 32% of individuals with VCFS developing a psychotic illness.
Individuals with VCFS thus form a unique group to identify and explore early symptoms and
biological correlates of psychosis. In this study, we examined if cortical gyrification pattern, i.e.
gyrification index (GI) can be a potential neurobiological marker for psychosis.
Method—GIs of 91 individuals with VCFS were compared with 29 siblings and 54 controls.
Further, 58 participants with VCFS, 21 siblings and 18 normal controls were followed up after 3
years and longitudinal changes in GI were compared. Additionally, we also correlated longitudinal
changes in GI in individuals with VCFS with prodromal symptoms of psychosis on the Scale of
Prodromal Symptoms (SOPS).
Result—Individuals with VCFS had significantly lower GIs as compared to their siblings and
normal controls. Longitudinal examination of GI did not reveal any significant group-time
interactions between the three groups. Further, longitudinal change in GI scores in the VCFS
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group was negatively correlated with positive prodromal symptoms, with the left occipital region
reaching statistical significance.
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Conclusion—The study confirms previous reports that individuals with VCFS have reduced
cortical folding as compared to normal controls. However over a period of three years, there is no
difference in the rate of change of GI among both individuals with VCFS and normal controls.
Finally, our results suggest that neuroanatomical alterations in areas underlying visual processing
may be an early marker for psychosis.
Keywords
VCFS; Gyrification index; prodromal symptoms; occipital cortex

1. Introduction
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Velocardiofacial syndrome (VCFS) results from a microdeletion spanning over 40 genes
(Carlson et al, 1997) at 22q11.2, with an estimated prevalence of 1 in 2000–4000 births
(Shprintzen, 2005). Physical features include a characteristic facial appearance, and cardiac
and pharyngeal abnormalities. Additionally, VCFS is associated with behavioral
abnormalities including disinhibition, impulsivity, schizoid features, social withdrawal, and
flat affect (Feinstein et al, 2002; Swillen et al, 1999). Significantly, it has been reported that
up to 32% individuals with VCFS develop a psychotic illness in adulthood (Arnold et al,
2001; Bassett and Chow, 1999; Green et al, 2009; Murphy et al, 1999; Sphrintzen et al,
1992). The high rate of psychosis in VCFS suggests that, with the exception of being the
offspring of a dual mating or the monozygotic co-twin of an affected individual, the specific
microdeletion of chromosome 22q11 associated with VCFS represents the highest known
risk factor for the development of schizophrenia. This strong association between
schizophrenia and VCFS implies that a gene or genes mapping to chromosome 22q11 may
play a role in the etiology of schizophrenia.
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It is therefore not surprising that several investigators have explored this unique relationship
between VCFS and schizophrenia. Qualitative (Chow et al, 1999; Lynch et al, 1995; Mitnick
et al, 1994; van Amelswoort et al, 2001; Vataja and Elomaa, 1998) and quantitative (Eliez et
al, 2000; 2001; Kates et al, 2001; 2006; Simon et al, 2005; Tan et al, 2009) neuroimaging
studies have identified neuroanatomic overlap between individuals with VCFS and
schizophrenia, including enlarged ventricles, midline brain abnormalities (e.g. cavum
septum pellucidum), and volumetric reductions in prefrontal, parietal, temporal and occipital
GM and WM, and hippocampal volumes. Similarly, studies of individuals with
schizophrenia (Cahn et al, 2002; Corsona et al, 1999; Davatzikos et al, 2005; Hazlett et al,
1999; Pearlson and Marsh, 1999; Pol et al, 2002; Shenton et al, 2001; Wright et al, 2000)
have reported reductions in the volumes of total and prefrontal GM, temporal and parietal
lobes, caudate nucleus, thalamus, hippocampus and amygdala.
Overlapping anomalies in cortical complexity have also been reported in studies of
individuals with schizophrenia and those with VCFS. The complexity of cortical folding has
been represented in most studies with the gyrification index (GI). Gyrification abnormalities
in schizophrenia have been reported in the left hemisphere (Sallet et al, 2003), left frontal
and right temporal regions (Harris et al, 2004a). Pre-existing differences in gyral folding
have also been identified as a potential trait marker for individuals who subsequently
develop schizophrenia. Harris et al (2004b) reported that right prefrontal lobe GI was
significantly increased in individuals who subsequently developed schizophrenia.
In individuals with VCFS, findings are variable. Whereas Bearden and colleagues (2009)
observed GI increases in the occipital lobe, Srivastava et al (2012) noted GI reductions in
Schizophr Res. Author manuscript; available in PMC 2013 May 01.
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frontal and parietal lobes relative to controls. In their cross-sectional sample, Srivastava and
colleagues further noted that GI in VCFS-affected youth ages 6–15 years (but not in
controls) decreased with age, particularly in the parietal lobes. Similarly, Schaer et al
showed a significant decrease in the GI in frontal (2006) and parietal lobes (2006, 2008,
2009) of adolescents and adults with VCFS relative to controls. Interestingly, the study by
Schaer and colleagues (2009) observed that relative to typical controls, individuals with
VCFS had differential rates of cortical maturation that were more magnified in patients who
later developed schizophrenia. However, neither study of cortical gyrification in VCFS
followed the same cohort over time to investigate longitudinal changes in GI.
In an effort to complement and extend previous studies, we examined longitudinal changes
in gyrification patterns in a cohort of youth with VCFS, and explored the extent to which
alterations in GI were associated with early symptoms of psychosis. We have previously
reported, in the same cohort, that among individuals with VCFS, contractions in the surface
morphology of the temporal cortex were associated with overall prodromal symptoms of
psychosis (Kates et al, 2011), and longitudinal decrements in volumes of temporal lobe GM
were associated specifically with positive prodromal symptoms of psychosis (Kates et al,
2011). The current report expands on these findings as well.
Based on previous GI studies in both VCFS and schizophrenia, we hypothesized that:
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Hypothesis 1a: Individuals with VCFS will have reduced GI relative to controls and
siblings.
Hypothesis 1b: On longitudinal assessment, individuals with VCFS will have a slower
rate of change in GI as compared to typically developing controls.
Hypothesis 2: GI patterns, particularly in the frontal and temporal regions, will be
associated with prodromal symptoms. We propose this hypothesis as our findings on
cortical surface morphology suggest that psychotic symptoms are related to change in
frontal and temporal cortices.

2. Materials and Methods (Details in Appendix I)
2.1. Participants
The current sample, described in Table 1, comprises data acquired for two studies:
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1.

A cross-sectional study (Study 1) of children with VCFS between the ages of 6 and
9 years, and age-matched community controls. This group of participants was not
invited for longitudinal assessments.

2.

A longitudinal study (Study 2) of 9–15 year old children with VCFS, their
unaffected siblings within the same age range, and age-matched community
controls. For Study 2, all participants were invited to return for a second time point,
three years after their initial visit.

The data from Study 1, and the baseline data from Study 2, are combined in this report to
form the “Baseline” sample (age range from 6–15 years). Data from the participants (9 to 15
years of age at baseline) who were followed longitudinally comprise the “Follow-up”
sample. At the first time point (Baseline visit, henceforth referred to as Time 1 or T1), all
participants underwent an MRI scan. At Follow-up visit (henceforth referred to as Time 2 or
T2), three (range: 1.5–5.3) years later, participants underwent a repeat MRI scan using the
same protocol as Time 1. In Study 2, attrition between T1 and T2 was 16% for individuals
with VCFS, 21% for siblings, and 37% for controls.

Schizophr Res. Author manuscript; available in PMC 2013 May 01.
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2.2. MRI acquisition
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Magnetic resonance imaging scans were acquired in the axial plane on a 1.5 T Philips
Gyroscan scanner (Philips Medical Systems, Best, The Netherlands). images were imported
into BrainImage (Reiss, 2004) for removal of non-brain tissue, and were subsequently
spatially normalized using a 3D Talairach grid (Kates et al, 1999; Talaraich and Tournoux,
1998), which was used to determine GI in the four major lobar regions (frontal, parietal,
temporal and occipital).
2.3. Calculation of Gyrification Index
GI was measured following a semi-automated protocol described by Schmitt and colleagues
(2002). GI is calculated as the ratio of the length of the inner perimeter of the cortex
(including the depths of the sulci) to the length of the outer perimeter (Zilles et al, 1988):
GI= Length of inner contour/ Length of outer contour
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Behavioral Assessments—The Scale of Prodromal Symptoms (SOPS) (Miller et al,
2003) was used to assess prodromal symptoms of psychosis. The SOPS is a clinician-based
instrument (based on self-report and observation) that categorizes prodromal symptoms into
four categories: Positive (P), Negative (N), Disorganized (DOS) and General (G) symptoms.
Total (T) score was calculated as the sum of P, N, DOS and G scores. For most assessments,
Total and Positive subscale scores were used.
Statistical Analyses—Data were analyzed using STATA SE 11.0. All major lobar
regions were examined – frontal, parietal, temporal and occipital. Further, as the two
hemispheres differ in their GI patterns due to functional specialization, left and right GI for
each lobe were analyzed separately (Armstrong et al, 1995). Cross-sectional analyses were
carried out using MANCOVA, with age and gender as covariates. For longitudinal analyses,
we used repeated measures MANOVA, controlling for gender. GI change score was
calculated as the difference between GI at T2 and T1. This change score was used in ZIP
regressions with P and Total scores. Throughout, we corrected for multiple comparisons
using Bonferroni correction; p<0.006 (0.05/8) was considered as statistically significant for
the cortical regions.

3. Results
3.1. Demographic Profile (Table 1)1
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At Time 1, as was expected due to the combination of the two samples, a significant
difference was noted in the ages between the three groups (p= 0.01). Neither gender
distribution (p= 0.22) nor handedness (p= 0.69) differed between groups. At time 2, the
three groups did not differ significantly in age (p= 0.87), gender (p= 0.78) or handedness (p=
0.49).
3.2. Cross-sectional Analyses
3.2.1. Comparison of GI among the three groups (MANCOVA) (Table 2 &3)—
Table 2 (df-3, 170) presents the GIs (average and SD) for lobar regions in the three groups at
the two time points. Table 3 reports the MANCOVA results comparing the GIs in the

1In study 2, participants who did not follow up for the second part of the study (11.9 years) were noted to be similar in age as
compared to the participants who followed up (12.5 years). This held true between the three groups as well. Further, no differences
were noted in the GIs of any lobar regions between these two groups. When the three groups were treated separately, only the siblings
who dropped out were noted to have significantly lower GIs in the frontal regions and left parietal region. These differences, however,
did not survive Bonferroni correction.

Schizophr Res. Author manuscript; available in PMC 2013 May 01.
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frontal, parietal, temporal and occipital regions of the three groups at each time point
controlling for age and gender.
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Significant differences were noted among the three groups at both time points. At T1,
significant differences were noted in the frontal (Right: F= 7.57, p= 0.00, Left: F=10.83, p=
0.00) and parietal regions (Right: F= 14.64, p= 0.00, Left: F=13.52, p= 0.00) bilaterally. At
T2, the three groups continued to differ significantly in the same regions (right frontal: F=
6.34, p= 0.00, Left frontal: F=9.11, p= 0.00, right parietal: F= 16.67, p= 0.00, left parietal:
F=12.66, p= 0.00) bilaterally. Post-hoc analyses revealed that these differences were driven
by participants in the VCFS group who had significantly lower GI’s in all regions than the
other two groups (reported in Table 2). GI scores were the highest for the sibling group, with
the exception of the right frontal and parietal regions, which were highest in community
controls.
3.3. Longitudinal Analyses

NIH-PA Author Manuscript

3.3.1. Comparison of GI among the three groups over the two time periods
(Repeated Measures MANOVA with gender as covariate) (Table 3)—Repeated
measures MANOVA (df- 2, 94) examining changes in GI over time showed no significant
group-X-time interactions. However, post-hoc analyses revealed a similar time effect in all
groups. GI’s among all three groups changed significantly over time (p<0.01), i.e., GI at
baseline in frontal, parietal and temporal regions was significantly higher than GI at followup among all three groups. These differences held when corrected for multiple analyses in
all regions except right parietal (p= 0.008). In both occipital lobes, the GI at follow-up was
not significantly different from the GI at baseline (right occipital lobe (F= 1.06, p= 0.31);
left occipital lobe (F= 0.74, p= 0.39)).
3.3.2. Correlations of GI with SOPS score (ZIP regression) (Table 4)—ZIP
analyses revealed negative correlations between GI change scores in all areas and the
positive SOPS score, suggesting that lower GI change scores were associated with positive
SOPS. SOPS Positive Symptom score correlated significantly with GI scores in right
temporal (p= 0.040), left frontal (p= 0.041), and left occipital (p= 0.002) lobes, while SOPS
total scores correlated with right frontal (p= 0.008), right parietal (p= 0.007) and both
occipital GI scores (right occipital region: p= 0.006, left occipital region: p= 0.018). When
Bonferroni - corrected for multiple comparisons, the negative association between SOPS
Positive symptoms and left occipital GI persisted. Similarly, a negative correlation between
right occipital GI and the SOPS Total score remained statistically significant, although the
parietal and frontal regions were close to surviving the correction.

NIH-PA Author Manuscript

4. Discussion
In this longitudinal study, individuals with VCFS were followed over a three year period,
along with their siblings and community controls. Our first hypothesis was partially
supported. Individuals with VCFS had lower gyrification indices relative to age and sexmatched siblings and community controls in frontal and parietal (but not temporal) lobes.
This pattern of lower baseline GI among individuals with VCFS was also noted in the same
regions during the follow-up visit 3 years later. Qualitative observations of anomalous
cortical gyrification, including pachygyria and polymicrogyria in the frontal and parietal
regions were among the earliest structural abnormalities reported in individuals with VCFS
(Bingham et al, 1998; Bird and Scrambler, 2000; Cramer et al, 1996; Ehara et al, 2000;
Ghariani et al, 2002; Kawame et al, 2000; Koolen et al, 2004; Sztriha et al, 2004;
Worthington et al, 2000). Schaer et al reported that compared to typically developing
individuals, those with VCFS had lower GIs in the frontal (2006) and parietal regions (2006,

Schizophr Res. Author manuscript; available in PMC 2013 May 01.
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2008, 2009). Similar to our finding, Schaer et al (2006) did not observe differences in the
temporal GIs among individuals with VCFS and typically developing controls. These GI
reductions in individuals with VCFS may reflect aberrant/ weaker intercortical connections
in frontal and parietal cortices. Barnea-Goraly et al (2003) reported reduced fractional
anisotropy in the frontal and parietal regions.
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Longitudinal analyses identified that GIs among all three groups decreased over the three
years. However, no significant differences were noted between the three groups. This time
effect was not noted in the occipital lobe, i.e., the rate of decrease in GI in the occipital lobe
is slower than other regions. Srivastava et al (2012) noted that, relative to typically
developing children, children with VCFS had both higher and lower rates of age-related
change in GI in various parts of the parietal lobe; however none of these changes were
significantly different. These authors do not report significant differences in the
developmental rates of the occipital lobe, although their cross-sectional results are not
directly comparable to our longitudinal findings. A longitudinal exploration of cortical
changes by our group (Kates, 2011) noted that changes in cortical morphology were similar
among individuals with VCFS, their siblings and typically developing controls. These
morphological changes represented changes in protrusions and contractions of the cortical
surface, putatively associated with changes in the local volumes of cortical brain regions
(Petersen, 2010). In contrast, our measure of gyrification represents changes in the degree of
cortical complexity or convolutions of the brain. As such, cortical gyrification can be used to
infer changes in the shape, as opposed to local volumes, of the cortical surface.
Our second hypothesis examined the association between longitudinal changes in GI and
development of psychosis. Several authors (Harris et al, 2004b; Jou et al, 2005) have
proposed that aberrant gyrification patterns influence the development of psychiatric
symptoms including psychosis. Harris et al (2004b) noted that abnormal GIs could be a trait
marker for schizophrenia. When we explored the correlation of rate of change of GI with the
incidence of prodromal symptoms, after correcting for multiple analyses, we found that
longitudinal decreases in GI in the left occipital lobe were associated with greater positive
scores whereas in the right occipital lobe they were associated with total SOPS scores. As
noted earlier, the rates of change of GI were the slowest in the occipital lobes as compared
to the other regions. However, in individuals with VCFS, greater longitudinal reduction in
GI in the occipital lobe was associated with positive symptoms. It is however still possible
that further longitudinal follow-up may reveal a catch-up in the change of GI in the occipital
regions. The differential rate of change in the occipital lobe and association with prodromal
symptoms suggests that occipital lobar connections may become dysfunctional or fail to
develop normally, thereby influencing onset or development of prodromal symptoms.
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Several studies (Schaer et al 2009, Bearden et al, 2007) have suggested that individuals with
VCFS have cortical abnormalities in the regions responsible for visuospatial functioning. In
a cross-sectional study of a similar age group, Bearden et al (2009) noted increased gyral
complexity in the occipital lobe. There are contradictory findings about the involvement of
the occipital lobe in schizophrenia, with some studies (Davatzikos et al, 2005; Onitsuka et
al, 2007; Zipursky et al, 1992) reporting reductions and others (Giuliani et al, 2005;
Goldstein et al, 1999; Shenton 2001) noting no significant changes. Onitsuka et al (2007)
have reported reductions in the gray matter areas of the visual association area. They further
suggest that these changes may contribute to early visual processing abnormalities noted in
schizophrenia.
We also noted that the right frontal and left parietal change scores attained near significance
with total SOPS scores. This was in the opposite direction of the occipital lobe, suggesting
that in individuals with prodromal symptoms, GIs in the frontal and parietal regions increase

Schizophr Res. Author manuscript; available in PMC 2013 May 01.
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on follow-up. This is also discrepant from the longitudinal trajectory noted in these regions
in all three groups; GIs in these regions decrease as a general rule. Accordingly, it appears
that when the direction of change in frontal and parietal cortical complexity deviates from
that of both neurotypical individuals and most subjects with VCFS, prodromal symptoms
appear. Further, the correlation with total scores and not positive scores suggest that these
areas may be involved in other symptoms including disorganization, negative and general or
may influence the intensity of the prodromal symptoms. Parietal and frontal cortical changes
have been reported in individuals with increased risk for developing schizophrenia (Prasad
et al, 2010). Further, our group (Kates et al, 2011) noted differential longitudinal trajectories
in parietal and frontal cortical surface morphology in individuals with VCFS at high risk for
developing schizophrenia. Most studies of schizophrenia associate positive symptoms with
the temporal lobe. Although we have recently noted associations between changes in
temporal gray matter volume and surface morphology and prodromal symptoms of
psychosis in individuals with VCFS (Kates, 2011), we were unable to demonstrate here an
association with changes in temporal lobe GI. It is possible that temporal GI changes may
become evident on further follow-up.
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GI reflects cortical folding and is established by the age of 6–9 months following which GI
decreases until it stabilizes in adulthood (Armstrong et al, 1995). The morphogenetic model
(Toro & Burnod, 2005) suggests that the cortical plate develops at a different rate than the
inner plate, which results in cortical folding. Van Essen (1997) discussed a mechanical
model which explains that the pattern of cortical folding is determined by the mechanical
tension exerted by the longer subcortico-cortical (in a radial fashion) and shorter local
intercortical axons (in a tangential manner) during development. More compact longer
axons and weaker local (cortical interconnections) axonal development leads to smaller gyri
with smaller sulci, thereby decreased GI. On the other hand, looser long radial axons and
stronger local interconnections lead to increased GI. Additionally, authors (Guerrini et al,
2000) have suggested that gyrification abnormalities can coexist due to vascular anomalies.
Schaer et al noted that individuals with congenital heart disease have reduced gyrification
than individuals with normal heart functioning. They proposed that these could be secondary
to a common genetic mechanism through TBX1 or the consequence of reduced blood flow
resulting from cardiac dysfunction. A final hypothesis that has been proposed is that
synaptic pruning may be involved in the formation of sulci and gyri. White et al (2003)
propose a model based on pruning of the connections in the sulci that can contribute to
further remodeling of the gyral system. Thus, measurement of GI provides some indication
of both neurodevelopmental (such as neuronal migration and proliferation leading to
alteration in neuronal tension and altered pruning) and neurodegenerative (including
vascular changes) processes. Our cross-sectional and longitudinal findings of differences in
GI among the three groups suggest that prodromal symptoms in VCFS may be a
developmental rather than degenerative process, although the influence of the latter process
cannot be ruled out completely.
Our results should be examined in the context of their limitations. Although we used a
previously validated (Kates et al., 1999) 3D Talaraich grid to identify lobar regions, our
method for measuring GI specifically was limited in its 2D anatomical definition.
Additionally, all statistical analyses were done using the most restrictive method (repeated
measures MANOVA and Bonferroni correction) available. While it demonstrates the
robustness of our findings (Keselman et al, 1991), it also increases the chances of Type II
errors. We also noted that siblings of VCFS had higher GI values as compared to typically
developing controls. A similar finding was noted in the rate of change of orbitolateral
cortical volumes examined in the same group (siblings had a greater increase in volumes
than typically developing controls). We believe that these changes may reflect a familial
influence rather than any particular genetic pattern. Further, we did not exclude controls who
Schizophr Res. Author manuscript; available in PMC 2013 May 01.
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had ADHD or learning disabilities to ensure a control sample that would appropriately
match for our higher functioning VCFS subjects. So their lower GI values may have
reflected their developmental challenges to some extent.
To summarize, the study affirms earlier findings that individuals with VCFS have reduced
cortical folding than typically developing individuals. The study also noted that GI in
individuals with VCFS changes at a rate similar to typical controls. However, this
longitudinal trajectory appears to be deviant in “high-risk” individuals with VCFS. Finally,
we identified significant associations between longitudinal alteration in the GI of the
occipital lobe and prodromal symptoms, raising the question of whether deficits in visual
processing in VCFS may represent a vulnerability marker for the development of psychosis.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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TABLE 1

Description of demographic profile of the three groups

NIH-PA Author Manuscript

Baseline Sample

VCFS (n-91)

Siblings (n-29)

Controls (n-54)

p-value

11.33(SD- 2.5)

12.27(SD- 2.11)

10.61(SD- 2.59)

0.01*

Male

47 (51.6%)

12 (41.4%)

33 (61.1%)

0.22

Female

44 (48.3%)

17 (58.6%)

21 (38.9%)

Right

80 (87.9%)

27(93.1%)

49 (90.7%)

Left

11 (12.1%)

2(6.9%)

5 (9.3%)

VCFS (n-58)

Siblings (n-21)

Control (n-18)

p-value

14.99 (SD- 2.05)

15.19 (SD- 2.15)

15.23 (SD- 2.01)

0.87

Male

30 (51.7%)

11 (52.4%)

11 (61.1%)

0.78

Female

28 (48.3%)

10 (47.6%)

7 (38.9%)

Right

49 (84.5%)

19 (90.5%)

17 (94.4%)

Left

9 (15.5%)

2 (9.5%)

1 (5.6%)

Age (Years)
Gender

Handedness

Follow-up Sample
Age (Years)

0.69

Gender

NIH-PA Author Manuscript

Handedness
0.49

*

p<0.05

NIH-PA Author Manuscript
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NIH-PA Author Manuscript

NIH-PA Author Manuscript

3.17
(0.46)

3.01
(0.40)

2.76
(0.45)

2.67
(0.41)

2.05
(0.36)

2.01
(0.29)

L Parietal

R Temporal

L Temporal

R Occipital

L Occipital

3.07
(0.41)

L Frontal

R Parietal

3.09
(0.36)

R Frontal

T1 (n=91)

2.05
(0.35)

1.99
(0.36)

2.45
(0.36)

2.49
(0.37)

2.71
(0.33)

2.91
(0.36)

2.82
(0.38)

2.81
(0.35)

T2 (n=58)

VCFS

2.17
(0.39)

2.82
(0.46)

2.78
(0.45)

2.97
(0.48)

3.23
(0.35)

3.47
(0.49)

3.21
(0.41)

3.26
(0.34)

T1(n=29)

2.19
(0.51)

2.17
(0.44)

2.61
(0.41)

2.68
(0.51)

3.03
(0.34)

3.21
(0.32)

3.08
(0.35)

3.04
(0.31)

T2(n=21)

Siblings

2.04
(0.47)

2.05
(0.53)

2.60
(0.53)

2.83
(0.51)

3.36
(0.44)

3.57
(0.43)

3.30
(0.35)

3.28
(0.39)

T1 (n=54)

2.05
(0.43)

2.05
(0.49)

2.49
(0.38)

2.60
(0.40)

3.04
(0.43)

3.37
(0.43)

3.04
(0.31)

3.09
(0.34)

T2 (n=18)

Controls

Description of GIs (mean (SD)) of the three study groups over the two time periods.
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NIH-PA Author Manuscript

14.64

1.48

2.25

Parietal

Temporal

Occipital

13.52

1.02

2.92

Parietal

Temporal

Occipital

0.0354

0.83

1.03

12.66

0.000*
0.3843

9.11

1.11

0.0000*

0.0839

1.60

16.67

0.000*
0.2215

6.34

F

0.0001*

P

0.4796

0.3826

0.0000*

0.0000*

0.3499

0.1946

0.0000*

0.0006*

P

T2 (n-97)

1.16

0.05

0.20

0.11

0.32

0.71

0.30

0.36

F

0.0141

0.9549

0.8212

0.8934

0.7273

0.4923

0.7427

0.6992

P

T2-T1 (n-97)
Group-Time Interaction

Applying Bonferroni correction for cortical regions: * p (0.05/8) = 0.006

10.83

Frontal

Left

7.57

Frontal

Right

F

T1 (n-174)

MANCOVA controlled for age and gender among the three diagnoses at T1 (df-2, 1, 170) & T2 (df-2, 1, 93) and repeated measures MANOVA,
controlled for gender (df- 2, 1, 93) between T1 and T2.
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TABLE 4

Zero-inflated Poisson regression (n=57)

NIH-PA Author Manuscript

Positive
Right

Total
(N+P+G+DOS)

Z

P

Z

P

Frontal

0.15

0.878

2.65

0.008

Parietal

−0.15

0.879

0.74

0.459

Temporal

−2.05

0.040

−0.69

0.491

Occipital

−0.77

0.440

−2.74

0.006*

Frontal

−2.05

0.041

−0.86

0.392

Parietal

−1.17

0.242

2.68

0.007

Temporal

−0.59

0.556

−0.31

0.758

Occipital

−3.09

0.002 *

−2.37

0.018

Left

Applying the Bonferroni correction: * p (0.05/ 8) = 0.006

NIH-PA Author Manuscript

Vuong Test: p<0.05 for all regressions.

NIH-PA Author Manuscript
Schizophr Res. Author manuscript; available in PMC 2013 May 01.

